Editorials

Rethinking the effectiveness of hypomethylating agents in myelodysplastic syndromes: the 50%-2-year wall

Department of Medicine and The Institute for Preventive Medicine, Tel-Aviv Sourasky Medical Center; Tel-Aviv University, School of Medicine
Tel-Aviv University, School of Medicine; Department of Hematology, Tel-Aviv Sourasky Medical Center
Haematologica Early view Jan 22, 2026 https://doi.org/10.3324/haematol.2025.300405